In vivo experiments, the growth of tumours from ACVRL1-knockdown HCT15 cells was completely retarded after mTKI treatment, leading to lower tumour weight and volume than the control group (Fig. 2F and Additional file 1: Figure S2D). This evidence concerns the gene ACVRL1 and neoplasm.